03:42 PM EST - Aeterna Zentaris Inc. : announced that the United States Patent and Trademark Office has granted a patent for the use of its oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency. Aeterna Zentaris Inc.
shares T.AEZ are trading up $0.01 at $0.40.
